LIFEVANTAGE CORP Inventory Adjustments
LIFEVANTAGE CORP (LFVN) had Inventory Adjustments of $500.00 thousand as of 2025-06-30, per its 10-K filed 2025-09-04.
Financial Statements › Notes › Inventory › Inventory, Net
us-gaap:InventoryAdjustments · last filed 2025-09-04
- 2025-06-30: Inventory Adjustments $500.00K.
- 2024-06-30: Inventory Adjustments $1.30M.
- 2023-06-30: Inventory Adjustments $1.30M.
- 2022-06-30: Inventory Adjustments $1.30M; Inventory Adjustments as first filed -$1.30M.
| Period end | Inventory Adjustments | Inventory Adjustments as first filed |
|---|---|---|
| 2025-06-30 | $500.00K 10-K · filed 2025-09-04 | |
| 2024-06-30 | $1.30M 10-K · filed 2025-09-04 | |
| 2023-06-30 | $1.30M 10-K · filed 2024-08-28 | |
| 2022-06-30 | $1.30M 10-K · filed 2023-08-28 | -$1.30M 10-K · filed 2022-08-23 |
| 2021-06-30 | $500.00K 10-K · filed 2022-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |